Seeing medicines

This biotechnology company is dedicated to the development of regenerative medicine treatments. Their primary objective is to restore and maintain vision in patients affected by macular degenerative diseases such as Age-related Macular Degeneration (AMD), Best Disease, and Stargardt Disease. Their innovative approach to treatment could potentially revolutionize the field of ophthalmology.